News | April 26, 2021
Lonza will invest CHF 200 mn to construct manufacturing complex
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
The country has constantly worked with the spirit of public-private partnership
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
The approval is for Ibrutinib tablets 560 mg, 420 mg, 280 mg and 140 mg strengths
The government has taken all the effective measures to make healthcare affordable
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
India produces 60% of the world’s vaccine
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
Subscribe To Our Newsletter & Stay Updated
